UPDATE: Birss J refuses permission to appeal in Genentech's Herceptin battle By Annsley Merelle Ward on Friday, May 23, 2014 AmeriKat appeal dosage regime patents formulation patents Genentech Hospira interim costs mr justice birss revocation +
Not pennies from heaven, but pounds for Sky By Jeremy on Wednesday, November 14, 2012 interim costs Jeremy Phillips speedy trial trade mark litigation +